Acucela: Acucela Provides Update on Emixustat Phase 3 Clinical Trial in Patients with Stargardt Disease

Acucela Inc. Acucela a clinicalstage ophthalmology company and whollyowned subsidiary of Kubota Pharmaceutical Holdings Co. Ltd. Tokyo 4596 announced today that the company has achieved over 65 subject enrollment in its ongoing phase 3 clinical trial inves...